Groundbreaking HIV study launches

Dr Makhema
Dr Makhema

The Botswana Harvard AIDS Institute Partnership (BHP) yesterday launched its inaugural clinical study to look into the effectiveness of antibodies in reducing the acquisition of HIV among high-risk female populations.The research explores a new idea for HIV prevention, investigators explained on Tuesday.

The study, which started in July, targets a maximum of 300 women aged between 18-40 among whom the HIV incidence is leading in sub-Saharan Africa, in addition to glaring disproportions among their male counterparts.

For instance, HIV incidence among 15 to 19-year-olds is reported to be three percent for males, and much more for females at seven percent.

Editor's Comment
Let’s fight GBV as a collective

Botswana for the longest time was known for her virulent peace with family being an enviable institution.As the media, we are also scared to be incessantly reporting on these bloody scenes where women are brutally murdered and worse, sometimes in front of their children and loved ones. Yes, we have reported cases where men were also brutally murdered by their loved ones, but such cases are a drop in the ocean.For the past two weeks, Botswana was...

Have a Story? Send Us a tip
arrow up